Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Search

Total 159 results found. Search for [ Vinita Gupta ]

Results 1 to 21 of 159
BusinessToday.In
November 13, 2019
Lupin Pharma has sold the entire stake (99.82%) in its Japanese subsidiary Kyowa to Unison's entity Plutus Ltd, Japan, for an enterprise value of $300 million, subject to closing adjustments


PB Jayakumar
New Delhi, November 12, 2019
The divestment will curtail 13 per cent global revenues of Lupin, which had posted Rs 16,369 crore consolidated revenues for the financial year ended March 31, 2019


BusinessToday.In
New Delhi, November 12, 2019
The deal proceeds will be utilised to strengthen Lupin's balance sheet as well as provide growth capital to support organic and inorganic initiatives for our focus markets, says Lupin CEO Vinita Gupta


PB Jayakumar
New Delhi, November 7, 2019
Lupin's net sales for the quarter stood at Rs 4,296 crore, an increase of 10.4 per cent compared to Rs 3,890 crore in the Q2FY19. The company posted a net loss of Rs 127 crore (after exceptional items) in Q2FY20, compared to Rs 266 crore net profit during the same quarter of the previous year


PTI
September 25, 2019
Homegrown pharma major Lupin on September 25 announced appointment of Jon Stelzmiller as the President of its US specialty business.


PB Jayakumar
New Delhi, July 22, 2019
Zydus Cadila, India's fourth-largest drug company by revenue, is banking big on research of new drugs, even though others have bowed out. Zydus expects the new drug business to grow to Rs 3,500 crore in four-five years


Team BT
June 19, 2019
Business Today felicitated the most powerful women in business in a glittering ceremony in Mumbai


PTI
February 5, 2019



PTI
February 4, 2019



PB Jayakumar
New Delhi, November 26, 2018
Market changes and increased regulatory oversight in the US have hurt Lupin, but India's third-biggest drug maker is making efforts to come back.


PTI
November 15, 2018



PB Jayakumar
New Delhi, October 29, 2018
A big transformation is happening in the global generic pharmaceutical industry. As a result, stocks of most major drug companies have done badly in the past one year.


PB Jayakumar
New Delhi, September 17, 2018
His new appointment is for a period of one year with effective October 1, 2018, said a press release.


PB Jayakumar
New Delhi, June 28, 2018
Enbrel had global brand sales of approximately $11.6 billion for the 12 months ending December 31, 2017, according to IQVIA.


PTI
May 31, 2018



P.B. Jayakumar
New Delhi, December 11, 2017
Margin erosion and regulatory hurdles are hitting Indian pharma companies hard in their biggest market.


E Kumar Sharma
New Delhi, October 11, 2017
Analysts see it as a good opportunity for Lupin but feel the company may need to wait for say another two years or so for benefits to accrue since they may first need to invest in certain things, putting additional pressure on the company.


PB Jayakumar
New Delhi, October 11, 2017
The acquisition of Symbiomix and the 'Solosec' franchise will help Lupin expand its women's health specialty business. Lupin will pay $50 million upfront and the remaining $100 million over the next five years.


PB Jayakumar
New Delhi, September 22, 2017
The company will pursue oncology, dermatology and respiratory as  three chosen therapy areas of focus and will straddle the entire value chain of products.


P. B. Jayakumar
New Delhi, September 16, 2017
The US-based global CEO of Lupin, Vinita Gupta, tells P.B. Jayakumar about the crises Indian drug companies are facing in the US.


PAGES 1 OF 8  12345